Ignite Creation Date:
2024-05-19 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06411249
Status:
RECRUITING
Last Update Posted:
2024-06-03
First Post:
2024-05-08
Brief Title:
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus SLE
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline